Tue, Jul 29, 2014, 12:04 AM EDT - U.S. Markets open in 9 hrs 26 mins

Recent

% | $
Click the to save as a favorite.

Exelixis, Inc. Message Board

  • wilderguide wilderguide Mar 18, 2013 4:17 PM Flag

    Trials should test combinations... Dr Dreicer on PC trial endpoints

    $$$$
    OncLive today 3/18/13 Dr Robert Dreicer on future endpoints of prostate cancer clinical trials. Interesting read...

    “Can you continue to anticipate, in an era where multiple trials are going to be done with multiple overlapping mechanisms, that we can still use overall survival as an endpoint?” he asked. “The likelihood, as we begin to start thinking about these new combinations, is that that’s not going to be acceptable.”

    GLTA

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • haven't listened to Dreicer's comments yet but trials have been using PFS with an eye on "quality-of-life" for awhile now, recognizing OS can require lengthy time periods to achieve. not that OS will not continue to be somewhat of a gold-standard for establishing efficacy over the long haul - some drugs (e.g., velcade) are approved without OS results.

      thanks wild. 'bout time to eat a button.

      Joe

 
EXEL
4.40+0.21(+5.01%)Jul 28 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.